Vaxcyte, Inc. (PCVX) stock
PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$64.69−3.93 (-5.73%)
Close on Nov 12, 2026Market cap $9.63BP/E –Yield 0.00%
Vaxcyte price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Vaxcyte's price to book ratio was 3.6× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.3× to 8.1×, with a median of 3.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.6× | +1.5 |
| 2025 | Dec 31, 2025 | 2.1× | −0.9 |
| 2024 | Dec 31, 2024 | 3.0× | −1.3 |
| 2023 | Dec 29, 2023 | 4.3× | −3.8 |
| 2022 | Dec 30, 2022 | 8.1× | +4.0 |
| 2021 | Dec 31, 2021 | 4.1× | +0.4 |
| 2020 | Dec 31, 2020 | 3.7× | – |
See a number that looks wrong?